AbbVie Director Jennifer L. Davis Resigns Effective Nov. 2, 2026
- AbbVie Class II director Jennifer L. Davis will resign from the board effective November 2, 2026.
- Davis notified the board on October 28, 2026, citing her recent appointment as CEO of Align Technology.
- Her resignation does not stem from any dispute or disagreement over the company's operations, policies or practices.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-121322), on November 02, 2026, and is solely responsible for the information contained therein.